Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Metrics to compare | 096530 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship096530PeersSector | |
|---|---|---|---|---|
P/E Ratio | −1,866.3x | 21.5x | −0.5x | |
PEG Ratio | 18.27 | 0.06 | 0.00 | |
Price/Book | 1.2x | 1.9x | 2.6x | |
Price / LTM Sales | 2.6x | 3.3x | 3.3x | |
Upside (Analyst Target) | 62.5% | 19.9% | 45.8% | |
Fair Value Upside | Unlock | 14.9% | 6.4% | Unlock |